OSR Holdings, Inc. (OSRH)

Market Cap	25.58M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	17.83M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,730
Open	1.460
Previous Close	1.470
Day's Range	1.400 - 1.640
52-Week Range	2.600 - 2.990
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OSRH

OSR Holdings, Inc. develops a portfolio of therapies and healthcare solutions in the United States, Europe, and South Korea. The company develops immunotherapy products, including VXM01, VXM04, VXM06, VXM08, and VXM10 for cancer treatment; DRT102-sp for the treatment of lumbar stenosis, disc herniaton, and spinal; DRT102-dt for dental augmentation; DRT102-nu for nonunion bone fracture; and DRT101 for osteoarthritis. It also provides medical devices. The company is based in Bellevue, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Sang Hoon Kim
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: OSRH
• Website: https://www.osr-holdings.com